UK markets closed
  • NIKKEI 225

    27,574.43
    -111.97 (-0.40%)
     
  • HANG SENG

    19,450.23
    +635.41 (+3.38%)
     
  • CRUDE OIL

    72.40
    +0.39 (+0.54%)
     
  • GOLD FUTURES

    1,800.40
    +2.40 (+0.13%)
     
  • DOW

    33,741.62
    +143.70 (+0.43%)
     
  • BTC-GBP

    13,856.88
    +39.54 (+0.29%)
     
  • CMC Crypto 200

    398.63
    +3.94 (+1.00%)
     
  • ^IXIC

    11,065.65
    +107.09 (+0.98%)
     
  • ^FTAS

    4,082.24
    -11.44 (-0.28%)
     

Merck and Co Digital Transformation Strategy Analysis Report 2022

Company Logo
Company Logo

Dublin, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The "Merck and Co Inc - Digital Transformation Strategies" report has been added to ResearchAndMarkets.com's offering.

This report provides insight into Merck's digital technology activities, including its digital transformation strategies, its accelerators, incubators, and other innovation programs, its technology initiatives, venture arm, investments, acquisitions and its estimated ICT budget.

Merck & Co., Inc. (Merck) is a multinational healthcare company engaged in the discovery, development, manufacture, and commercialization of prescription medicines, biological therapies, vaccines, and animal health products. The company comprises two operating segments namely Pharmaceutical and Animal Health.

The Pharmaceutical segment offers human health pharmaceutical products and vaccines. The company's human health pharmaceutical product portfolio comprises therapeutics and preventive agents. Its vaccine product portfolio comprises adult, adolescent and pediatric vaccines.

The Animal Health segment is engaged in the discovery, development, manufacture, and commercialization of veterinary pharmaceutical products and vaccines.

The company is using several emerging technologies such as 3D printing, AI, ML, big data, and blockchain among others, has launched accelerator and incubator programs, and is partnering, investing and acquiring digital companies to quickly develop new drugs and improve operational efficiency.

Scope

Merck is exploring and utilizing technologies including 3D printing, AI & machine learning (ML), big data, connected care, blockchain, cloud, IoT, virtual & augmented reality, wearable tech, and genomics to accelerate drug discovery and development, improve supply chain efficiency, and ensure consistent product quality.

Reasons to Buy

  • Gain insights into Merck's digital transformation strategies.

  • Gain insights into its technology themes under focus.

  • Gain insights into its various product launches, partnerships, investments, and acquisitions.

Key Topics Covered:

  • Overview

  • Digital Transformation Strategy

  • Accelerators, Incubators, and other Innovation Programs

  • Technology Focus

  • Technology Initiatives

  • Venture Arm

  • Investments

  • Acquisitions

  • Partnership, Acquisition Network Map

  • ICT Budgets Contracts

  • Key Executives

Companies Mentioned

  • Saama

  • Absci

  • Hyfe

  • Philips

  • Facebook

  • IBM

  • KPMG

  • Walmart

  • SAP

  • Evidation

  • Syapse

  • Corning

  • Seeq

  • Invonto

  • Geisinger

  • Volansi

  • AWS

  • Accenture

  • Appian

  • PreciseDX

  • VastBiome

  • GNS Healthcare

  • Syapse

  • PathAI

  • Clinithink

  • Prognos

  • Tag-n-Trac

  • Verana Health

  • Antidote

  • M2GEN

  • Aerosafe Global

  • Ayogo

  • Ciox Health

  • TriNetX

  • Arcadia Healthcare Solutions

  • ClearDATA

  • Strata Oncology

  • Transcarent

  • Koneksa

  • Navigating Cancer

  • Volansi

  • Zapata Computing Inc

  • Absci

  • IdentiGen

  • Quantified Ag

  • Antelliq.

For more information about this report visit https://www.researchandmarkets.com/r/eq7ul7

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900